SCHEMBL1029498

SCHEMBL1029498

CCCNCCOc1ccc(NS(=O)(=O)c2ccc(OC(F)F)cc2)c(C)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 4/20 0.41
PKM P14618 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 2/20 0.38
SQSTM1 Q13501 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
HTT P42858 4/20 0.36
LMNA P02545 4/20 0.36
TSHR P16473 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
EDNRA P25101 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4243947 0.99 KIT (0.41) KITPKMMAPTKDM4ESQSTM1
SCHEMBL1033640 0.89 PKM (0.39) PKMMAPTKDM4ESQSTM1KEAP1
Hydrochloric Acid SCHEMBL4244176 0.89 PKM (0.39) PKMMAPTKDM4ESQSTM1KEAP1
SCHEMBL1032629 0.89 LMNA (0.39) KITPKMMAPTKDM4ESQSTM1
Hydrochloric Acid SCHEMBL4240174 0.88 LMNA (0.39) KITPKMMAPTKDM4ESQSTM1
SCHEMBL1033689 0.87 PKM (0.43) PKMMAPTKDM4ESQSTM1KEAP1
SCHEMBL1031574 0.86 CCR9 (0.44) PKMMAPTKDM4ESQSTM1KEAP1
Hydrochloric Acid SCHEMBL4251154 0.86 PKM (0.42) PKMMAPTKDM4ESQSTM1KEAP1
SCHEMBL1028955 0.85 TRPV1 (0.35) PKMMAPTKDM4ESQSTM1KEAP1
SCHEMBL1033616 0.85 PKM (0.39) PKMMAPTKDM4ESQSTM1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013179-B1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO KG (DE) 2011-01-19 EP disclosed
EP-2013179-A1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR Abbott GmbH & Co. KG (DE) 2009-01-14 EP disclosed
WO-2007118859-A1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO. KG (DE) 2007-10-25 WO disclosed